BMC pharmacology & toxicology | VOL. 22
Read

Folic acid modified TPGS as a novel nano-micelle for delivery of nitidine chloride to improve apoptosis induction in Huh7 human hepatocellular carcinoma.

Publication Date Jan 6, 2021

Abstract

The development of novel and effective drugs for targeted human hepatocellular carcinoma still remains a great challenge. The alkaloid nitidine chloride (NC), a component of a traditional Chinese medicine, has been shown to have anticancer properties, but doses at therapeutic levels have unacceptable side effects. Here we investigate folic acid modified D-α-tocopheryl polyethylene glycol 1000 succinate (TPGS-FA) as a potential carrier for controlled delivery of the drug. Synthesized TPGS-FA was characterized by FTIR, UV-visible and 1H NMR spectroscopy, and TPGS loaded with NC was evaluated for its ability to induce apoptosis in Huh7 cells by Annexin V/PI and MTT assays, and observed by laser scanning confocal microscopy and inverted phase contrast microscopy. TPGS-FA/NC complexes were prepared successfully, and were homogenious with a uniform size of ~ 14 nm diameter. NC was released from the TPGS-FA/NC complexes in a controlled and sustained manner under physiological conditions (pH 7.4). Furthermore, its cytotoxicity to hepatocarcinoma cells was greater than that of free NC. TPGS-FA is shown to be useful carrier for drugs such as NC, and TPGS-FA/NC could potentially be a potent and safe drug for the treatment of hepatocellular carcinoma.

Concepts
Powered ByUnsilo

Nitidine Chloride
Apoptosis In Huh7 Cells
Inverted Phase Contrast Microscopy
Huh7 Human Hepatocellular Carcinoma
Unacceptable Side Effects
Confocal Microscopy
Human Hepatocellular Carcinoma
Huh7 Cells
1H NMR Spectroscopy
Component Of Chinese Medicine

Introducing Weekly Round-ups!Beta

Powered by R DiscoveryR Discovery

Round-ups are the summaries of handpicked papers around trending topics published every week. These would enable you to scan through a collection of papers and decide if the paper is relevant to you before actually investing time into reading it.

Coronavirus Research Articles published between Aug 01, 2022 to Aug 07, 2022

R DiscoveryAug 08, 2022
R DiscoveryArticles Included:  5

Introduction: The corona virus disease (COVID)-19 is a severe acute respiratory syndrome (SARS-CoV-2) which is posing a great threat to mankind and ha...

Read More

Climate change Research Articles published between Aug 01, 2022 to Aug 07, 2022

R DiscoveryAug 08, 2022
R DiscoveryArticles Included:  5

We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cooki...

Read More

Good health Research Articles published between Aug 01, 2022 to Aug 07, 2022

R DiscoveryAug 08, 2022
R DiscoveryArticles Included:  2

Don’t have an account? Create a Free Account If you don't remember your password, you can reset it by entering your email address and clicking the Res...

Read More

Quality Of Education Research Articles published between Aug 01, 2022 to Aug 07, 2022

R DiscoveryAug 08, 2022
R DiscoveryArticles Included:  2

Introduction: In 2014 the Accreditation Council for Graduate Medical Education modified adult training requirements for child neurology certification ...

Read More

Gender Equality Research Articles published between Aug 01, 2022 to Aug 07, 2022

R DiscoveryAug 08, 2022
R DiscoveryArticles Included:  3

Introduction: Opioid use disorder (OUD) is characterized as a problematic cycle of substance intoxication and binging, followed by associated withdraw...

Read More

Coronavirus Pandemic

You can also read COVID related content on R COVID-19

R ProductsCOVID-19

ONE PROBLEM . ONE PURPOSE . ONE PLACE

Creating the world’s largest AI-driven & human-curated collection of research, news, expert recommendations and educational resources on COVID-19

COVID-19 Dashboard

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on “as is” basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The Copyright Law.